Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|January 14, 1998
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpressionM Marone, G Scambia, C Giannitelli, et al.
International Journal of Oncology|November 18, 2000
p21WAF1/CIP1 protein expression in primary ovarian cancerG Ferrandina, A Stoler, A Fagotti, et al.
Bone Marrow Transplantation|July 5, 2001
High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term resultsM G Salerno, G Ferrandina, S Greggi, et al.
Journal of Chemotherapy (Florence, Italy)|April 13, 2011
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wallG Corrado, A di Stefano, V Salutari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of recombinant human interferon-alpha 2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancerG Scambia, P B Panici, F Battaglia, et al.
Cancer Research|December 11, 1997
Methyl-p-hydroxyphenyllactate-esterase activity in breast cancer: a potentially new prognostic factor in short-term follow-upA Carbone, F G Serra, G Ferrandina, et al.
Oncology|March 8, 2000
Bcl-2, Bax, Bcl-x(L) and Bcl-x(S) expression in neoplastic and normal endometriumM Marone, G Ferrandina, G Macchia, et al.
British Journal of Cancer|August 1, 1995
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapyG Scambia, P Benedetti-Panici, G Ferrandina, et al.
International Journal of Cancer|April 22, 1996
Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosisM Maurizi, G Almadori, G Cadoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinomaG Almadori, G Cadoni, P Cattani, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|January 14, 1998
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpressionM Marone, G Scambia, C Giannitelli, et al.
International Journal of Oncology|November 18, 2000
p21WAF1/CIP1 protein expression in primary ovarian cancerG Ferrandina, A Stoler, A Fagotti, et al.
Bone Marrow Transplantation|July 5, 2001
High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term resultsM G Salerno, G Ferrandina, S Greggi, et al.
Journal of Chemotherapy (Florence, Italy)|April 13, 2011
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wallG Corrado, A di Stefano, V Salutari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of recombinant human interferon-alpha 2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancerG Scambia, P B Panici, F Battaglia, et al.
Cancer Research|December 11, 1997
Methyl-p-hydroxyphenyllactate-esterase activity in breast cancer: a potentially new prognostic factor in short-term follow-upA Carbone, F G Serra, G Ferrandina, et al.
Oncology|March 8, 2000
Bcl-2, Bax, Bcl-x(L) and Bcl-x(S) expression in neoplastic and normal endometriumM Marone, G Ferrandina, G Macchia, et al.
British Journal of Cancer|August 1, 1995
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapyG Scambia, P Benedetti-Panici, G Ferrandina, et al.
International Journal of Cancer|April 22, 1996
Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosisM Maurizi, G Almadori, G Cadoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinomaG Almadori, G Cadoni, P Cattani, et al.
Pageof 18